+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Group Typing Market by Product Type, Technology, End User, Application - Global Forecast to 2030- Product Image
Blood Group Typing Market by Product Type, Technology, End User, Application - Global Forecast to 2030- Product Image
Sale

Blood Group Typing Market by Product Type, Technology, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989627
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Group Typing Market grew from USD 3.63 billion in 2024 to USD 3.93 billion in 2025. It is expected to continue growing at a CAGR of 7.85%, reaching USD 5.72 billion by 2030.

Shaping the Future of Blood Group Typing

The landscape of blood group typing has evolved into a cornerstone of modern healthcare, underpinning critical procedures from transfusion management to transplantation compatibility. With the growing complexity of patient care and the pressing need for rapid, accurate diagnostics, blood group typing has transcended its traditional role to become an integral component of personalized medicine and public health preparedness.

This report delivers an in-depth examination of the key factors shaping the blood group typing market, including technological breakthroughs, regulatory trajectories, and shifting end-user demands. By contextualizing the markets progression against the backdrop of global healthcare priorities and demographic trends, stakeholders will gain clarity on the drivers of innovation and the emerging opportunities that promise to redefine industry standards.

Decision-makers will find actionable analysis that bridges technical rigor with strategic foresight. The insights presented here cater to clinical laboratory directors, procurement executives, technology vendors, and policy makers seeking to align their initiatives with the evolving demands of precision diagnostics and patient safety.

Emerging Forces Redefining the Market Landscape

Over the last decade, the blood group typing market has witnessed transformative shifts propelled by advances in molecular diagnostics and automation. Innovations such as real-time and digital PCR have accelerated turnaround times while improving sensitivity, enabling laboratories to detect rare phenotypes and atypical antibodies with unprecedented accuracy.

Simultaneously, the integration of laboratory information systems with high-throughput analyzers has streamlined workflows and reduced human error. Automation platforms have moved beyond simple sample handling to offer complete end-to-end solutions, from specimen accessioning to result reporting, facilitating scalability for high-volume testing environments.

Regulatory frameworks have also adapted swiftly, with agencies endorsing more stringent validation protocols for reagents and devices. This has fostered robust quality controls and propelled manufacturers to invest in next-generation materials and software platforms. As the convergence of digital health, cloud connectivity, and artificial intelligence gains momentum, the market is poised for further disruption that will reshape diagnostic paradigms and patient care pathways.

Assessing the Impact of U.S. Tariff Policies

In 2025, the imposition of updated tariffs by the United States has reshaped the cost structure for imported instruments, reagents, and software solutions. These measures introduced additional duties on key components used in automated blood typing systems and specialized reagents, impacting manufacturers with international supply chains.

As a result, vendors have recalibrated pricing strategies and absorbed a portion of the duty increases to remain competitive. Some have relocated critical manufacturing steps or consolidated regional distribution centers to mitigate the financial implications. The ripple effect has also prompted laboratory procurement teams to reevaluate sourcing decisions and negotiate more flexible contracts that account for tariff volatility.

While the short-term effect has been upward pressure on unit costs, proactive industry responses-including strategic stockpiling, long-term agreements with raw material suppliers, and regional partnerships-have cushioned end users against supply disruptions. This period of adjustment underscores the importance of agile supply chain management and collaborative vendor relationships to sustain operational resilience.

Deep Dive into Market Segmentation Dynamics

A thorough examination of market segmentation reveals nuanced growth drivers and competitive dynamics across multiple categories. When considering product type, instruments segment performance hinges on demand for automated blood typers and gel card analyzers, while the reagents sector thrives on the adoption of antisera reagents, reagent red blood cells and screening cells. Growth in software and services is stimulated by investments in LIS integration alongside support and maintenance offerings.

Technological segmentation indicates that flow cytometry and gel centrifugation continue to serve high-volume blood centers, whereas microplate agglutination finds favor in decentralized labs. The surge in PCR adoption, driven by digital PCRs precision and real-time PCRs speed, underscores an industry shift toward molecular approaches for high-sensitivity antigen and antibody detection.

End users present distinct consumption patterns, with government and private blood banks leading bulk reagent purchases, hospital-based and independent clinical laboratories demanding integrated systems, and private and public hospitals emphasizing rapid pretransfusion testing turnaround. Application-driven segmentation highlights the critical role of donor screening, covering both blood typing and infectious disease screening, alongside newborn screening initiatives and pretransfusion compatibility testing.

By overlaying these segmentation lenses, stakeholders can pinpoint white-space opportunities, such as enhancing reagent portfolios for molecular assays or tailoring software modules to the specific workflow needs of decentralized diagnostic centers.

Regional Market Nuances Uncovered

Regional analysis illustrates divergent trajectories shaped by healthcare infrastructure, regulatory environments and demographic profiles. In the Americas, a robust network of centralized blood centers and advanced hospital systems drives consistent demand for high-throughput automated solutions, while cross-border collaborations in North and Latin America foster reagent standardization and harmonized testing protocols.

In Europe, the Middle East and Africa, the landscape is highly heterogeneous. Western Europe leads with sophisticated molecular laboratories and comprehensive quality frameworks, whereas emerging markets in Eastern Europe, the Gulf region and Africa present growth potential through capacity-building programs and public-private partnerships aimed at expanding blood safety initiatives.

The Asia-Pacific region stands out for its dual pace of modernization and expansion. Mature markets in Japan and Australia increasingly adopt digital PCR and integrated laboratory automation, whereas Southeast Asia and South Asia report rising investments in regional blood screening facilities to support growing healthcare access initiatives and address transfusion-transmissible infection risks.

Understanding these regional nuances enables market participants to align product launches, localization strategies and partnerships with the specific operational priorities and regulatory landscapes of each territory.

Leading Players Driving Industry Momentum

The competitive arena is characterized by a mix of established diagnostics conglomerates and specialized niche providers. Major players have expanded their portfolios through strategic acquisitions, collaborations and R&D alliances to deliver end-to-end blood typing ecosystems that integrate hardware, consumables and software services.

Notable innovations include advanced gel card platforms from global leaders that reduce hands-on time, and reagent manufacturers developing next-gen antisera with enhanced specificity for rare antigens. Software vendors are responding with modular designs that facilitate seamless integration with laboratory information management systems and offer real-time analytics dashboards for performance optimization.

Mid-sized companies continue to differentiate through regionally tailored reagent kits and localized technical support, carving out competitive advantages in emerging markets. A growing number of partnerships between device manufacturers and healthcare networks underscores an industry-wide shift toward outcome-based contracts, where service agreements are linked to predefined performance metrics.

Strategic Imperatives for Industry Stakeholders

Industry leaders must calibrate their strategies to balance innovation, cost management and regulatory compliance. Manufacturers should prioritize modular automation platforms that can scale with fluctuating testing volumes, ensuring both high-throughput capacity and flexibility for smaller laboratories.

Investing in reagent formulations compatible with multiple analyzer brands can mitigate customer reluctance around capital equipment lock-in, fostering broader adoption. On the software front, embedding predictive maintenance and remote troubleshooting capabilities will reduce downtime and enhance overall laboratory efficiency.

Strategic alliances with regional distributors and local health authorities can facilitate market entry in underpenetrated territories while demonstrating commitment to capacity-building. Furthermore, adopting value-based contracting models can create shared incentives focused on improving diagnostic accuracy and reducing total cost of ownership.

By aligning product roadmaps with emerging clinical needs-such as expanded antigen profiling for precision transfusion-organizations will be well-positioned to capitalize on evolving market demands.

Rigorous Approach Underpinning Research Validity

The research foundation combines primary insights from interviews with laboratory directors, procurement leaders and technical specialists, supplemented by secondary analysis of peer-reviewed journals, regulatory filings and industry white papers. Data triangulation techniques were employed to validate emerging trends and ensure consistency across multiple information sources.

Qualitative assessments evaluated technology adoption drivers, competitive positioning and customer satisfaction benchmarks, while quantitative analysis examined historical shipment data, company financial disclosures and regulatory approval timelines. Regional workshops and expert roundtables provided contextual grounding, illuminating localized challenges and adoption barriers.

To mitigate bias, a structured validation process engaged external advisors and industry consultants to review key findings. Statistical outlier analysis and sensitivity testing were conducted on critical data points to strengthen the robustness of conclusions. A transparent documentation protocol was maintained throughout, ensuring reproducibility and auditability of the methodological approach.

Key Takeaways and Future Outlook

The blood group typing market stands at the intersection of technological innovation and evolving clinical imperatives, with molecular diagnostics, automation and digital integration driving the next wave of growth. While recent tariff adjustments have introduced short-term cost pressures, the markets resilience is anchored in collaborative supply chain strategies and adaptive pricing models.

Segmentation analysis highlights targeted opportunities across product types, technologies, end users and applications, revealing that molecular platforms and integrated software services will play an increasingly central role. Regional insights point to sustained demand in mature economies alongside significant expansion in emerging markets, underpinned by capacity-building and public health initiatives.

As industry stakeholders navigate this dynamic landscape, the ability to align innovation with operational agility and regulatory compliance will determine competitive positioning. This report offers a comprehensive roadmap for leveraging market insights to optimize product portfolios, streamline workflows and drive long-term value creation in an increasingly complex healthcare environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Instruments
      • Automated Blood Typers
      • Gel Card Analyzers
    • Reagents
      • Antisera Reagents
      • Reagent Red Blood Cells
      • Screening Cells
    • Software & Services
      • LIS Integration
      • Support & Maintenance
  • Technology
    • Flow Cytometry
    • Gel Centrifugation
    • Microplate Agglutination
    • PCR
      • Digital PCR
      • Real-Time PCR
  • End User
    • Blood Banks
      • Government Blood Banks
      • Private Blood Banks
    • Clinical Laboratories
      • Hospital Based Laboratories
      • Independent Laboratories
    • Hospitals & Diagnostic Centers
      • Private Hospitals
      • Public Hospitals
  • Application
    • Donor Screening
      • Blood Typing
      • Infectious Disease Screening
    • Newborn Screening
    • Pretransfusion Testing
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Ortho Clinical Diagnostics, Inc.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Grifols, S.A.
  • Bio-Rad Laboratories, Inc.
  • Immucor, Inc.
  • Sysmex Corporation
  • BioMérieux SA
  • Quotient Limited
  • Fujirebio Holdings, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Group Typing Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Automated Blood Typers
8.2.2. Gel Card Analyzers
8.3. Reagents
8.3.1. Antisera Reagents
8.3.2. Reagent Red Blood Cells
8.3.3. Screening Cells
8.4. Software & Services
8.4.1. LIS Integration
8.4.2. Support & Maintenance
9. Blood Group Typing Market, by Technology
9.1. Introduction
9.2. Flow Cytometry
9.3. Gel Centrifugation
9.4. Microplate Agglutination
9.5. PCR
9.5.1. Digital PCR
9.5.2. Real-Time PCR
10. Blood Group Typing Market, by End User
10.1. Introduction
10.2. Blood Banks
10.2.1. Government Blood Banks
10.2.2. Private Blood Banks
10.3. Clinical Laboratories
10.3.1. Hospital Based Laboratories
10.3.2. Independent Laboratories
10.4. Hospitals & Diagnostic Centers
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Blood Group Typing Market, by Application
11.1. Introduction
11.2. Donor Screening
11.2.1. Blood Typing
11.2.2. Infectious Disease Screening
11.3. Newborn Screening
11.4. Pretransfusion Testing
12. Americas Blood Group Typing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood Group Typing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood Group Typing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ortho Clinical Diagnostics, Inc.
15.3.2. Abbott Laboratories
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Grifols, S.A.
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Immucor, Inc.
15.3.7. Sysmex Corporation
15.3.8. BioMérieux SA
15.3.9. Quotient Limited
15.3.10. Fujirebio Holdings, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD GROUP TYPING MARKET MULTI-CURRENCY
FIGURE 2. BLOOD GROUP TYPING MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD GROUP TYPING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD GROUP TYPING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATED BLOOD TYPERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY GEL CARD ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTISERA REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REAGENT RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SCREENING CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY LIS INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SUPPORT & MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY GEL CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MICROPLATE AGGLUTINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY GOVERNMENT BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD TYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRETRANSFUSION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 74. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 76. CANADA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 77. CANADA BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 78. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 80. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. CANADA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 82. CANADA BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 83. CANADA BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. CANADA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 147. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 159. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 183. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. ITALY BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. ITALY BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 186. ITALY BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 187. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 189. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. ITALY BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 191. ITALY BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 192. ITALY BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 193. ITALY BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 195. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 198. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 199. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 201. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 243. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 245. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 246. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 247. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 267. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. QATAR BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. QATAR BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 270. QATAR BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 271. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 273. QATAR BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. QATAR BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 275. QATAR BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 276. QATAR BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 277. QATAR BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. QATAR BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 279. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 281. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 282. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 283. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 285. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 287. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 288. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 289. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 315. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 318. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 319. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 320. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 321. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 323. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 324. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 325. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 327. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 329. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 330. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 331. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 333. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 335. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 336. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 337. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2030 (USD MILLION)
TABLE 339. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 343. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-203

Companies Mentioned

The companies profiled in this Blood Group Typing market report include:
  • Ortho Clinical Diagnostics, Inc.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Grifols, S.A.
  • Bio-Rad Laboratories, Inc.
  • Immucor, Inc.
  • Sysmex Corporation
  • BioMérieux SA
  • Quotient Limited
  • Fujirebio Holdings, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.72 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Group Typing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User - Product Image

Blood Group Typing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • Report
  • 112 Pages
  • Global
From
Blood Group Typing Market Report 2025 - Product Image

Blood Group Typing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Blood Group Typing - Global Strategic Business Report - Product Image

Blood Group Typing - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Blood Group Typing Market Report and Forecast 2024-2032 - Product Image

Blood Group Typing Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Blood Group Typing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Group Typing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From

About the Blood Typing Market

The Blood Typing market within the context of Coagulation and Hemostasis Testing is a specialized field of laboratory testing that focuses on the identification of blood types and the detection of antibodies in the blood. This type of testing is used to diagnose and monitor a variety of conditions, including hemophilia, thrombosis, and other bleeding disorders. It is also used to determine compatibility for blood transfusions and organ transplants. Blood typing is typically performed using a variety of techniques, such as agglutination, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR). The Blood Typing market is a highly competitive field, with a variety of companies offering products and services. Some of the major players in the market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.